Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pharmaceutical patent analyst

Showing results (1-10 of 493) with videos related to

Pageof 50
Sort By:
Pharmaceutical Patent Analyst|November 10, 2021
Patent highlights June-July 2021Hermann Am Mucke
Pharmaceutical Patent Analyst|January 14, 2021
Patent highlights August-September 2020Hermann Am Mucke
Pharmaceutical Patent Analyst|February 16, 2022
Drug repurposing of adapalene for melanoma treatmentMaricruz Anaya-Ruiz, Martin Perez-Santos
Pharmaceutical Patent Analyst|June 11, 2019
Opposing a granted patent in the USA: post grant and <i>inter partes</i> reviewPaul A Ragusa, Zichao Zhang
Pharmaceutical Patent Analyst|June 11, 2019
Extended scope of the patent term extension South Korea follows Japan: 'substantially identical' scope is 'extended'Takeshi S Komatani
Pharmaceutical Patent Analyst|April 4, 2022
Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsiesAlshaima'a M Qunies, Kyle A Emmitte
Pharmaceutical Patent Analyst|October 16, 2019
Secondary patents: innovator and generic strategiesSaritha Kiran, Sivakami Dhulap, Mohan Kulkarni
Pharmaceutical Patent Analyst|June 2, 2015
New changes in US patent term adjustment calculations after Novartis v. LeeElizabeth A Doherty, Rebecca M McNeill
Pharmaceutical Patent Analyst|June 2, 2015
10 years after implementation of TRIPS obligations in IndiaMahesh D Pawar
Pharmaceutical Patent Analyst|May 18, 2021
Patent highlights December 2020-January 2021Hermann Am Mucke
Pageof 50

Showing results (1-10 of 493) with videos related to

Sort By:
Pageof 50
Pharmaceutical Patent Analyst|November 10, 2021
Patent highlights June-July 2021Hermann Am Mucke
Pharmaceutical Patent Analyst|January 14, 2021
Patent highlights August-September 2020Hermann Am Mucke
Pharmaceutical Patent Analyst|February 16, 2022
Drug repurposing of adapalene for melanoma treatmentMaricruz Anaya-Ruiz, Martin Perez-Santos
Pharmaceutical Patent Analyst|June 11, 2019
Opposing a granted patent in the USA: post grant and <i>inter partes</i> reviewPaul A Ragusa, Zichao Zhang
Pharmaceutical Patent Analyst|June 11, 2019
Extended scope of the patent term extension South Korea follows Japan: 'substantially identical' scope is 'extended'Takeshi S Komatani
Pharmaceutical Patent Analyst|April 4, 2022
Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsiesAlshaima'a M Qunies, Kyle A Emmitte
Pharmaceutical Patent Analyst|October 16, 2019
Secondary patents: innovator and generic strategiesSaritha Kiran, Sivakami Dhulap, Mohan Kulkarni
Pharmaceutical Patent Analyst|June 2, 2015
New changes in US patent term adjustment calculations after Novartis v. LeeElizabeth A Doherty, Rebecca M McNeill
Pharmaceutical Patent Analyst|June 2, 2015
10 years after implementation of TRIPS obligations in IndiaMahesh D Pawar
Pharmaceutical Patent Analyst|May 18, 2021
Patent highlights December 2020-January 2021Hermann Am Mucke
Pageof 50